These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3752975)

  • 1. Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.
    Hirschhorn L; Neu HC
    Antimicrob Agents Chemother; 1986 Jul; 30(1):143-6. PubMed ID: 3752975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
    Hirschhorn L; Neu HC
    Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
    Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
    Smith BR; LeFrock JL; Donato JB; Joseph WS; Weber SJ
    Antimicrob Agents Chemother; 1986 Feb; 29(2):355-8. PubMed ID: 3717937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
    Hardy DJ; Swanson RN; Hensey DM; Ramer NR; Bower RR; Hanson CW; Chu DT; Fernandes PB
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1768-74. PubMed ID: 3435123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
    Eliopoulos GM; Moellering AE; Reiszner E; Moellering RC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):514-20. PubMed ID: 3935046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Fernandes PB; Chu DT; Bower RR; Jarvis KP; Ramer NR; Shipkowitz N
    Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
    Chin NX; Figueredo VM; Novelli A; Neu HC
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial spectrum of Win 49375.
    Jacobus NV; Tally FP; Barza M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):104-7. PubMed ID: 6476813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Eur J Clin Microbiol; 1986 Feb; 5(1):18-22. PubMed ID: 2938944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
    Digranes A; Dibb WL
    Chemotherapy; 1988; 34(4):298-307. PubMed ID: 3208547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Wise R; Andrews JM; Ashby JP; Matthews RS
    Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
    Pohlod DJ; Saravolatz LD
    Antimicrob Agents Chemother; 1984 Mar; 25(3):377-9. PubMed ID: 6326666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
    Thompson KD; O'Keefe JP; Tatarowicz WA
    Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial resistance to fluoroquinolones.
    Neu HC
    Rev Infect Dis; 1988; 10 Suppl 1():S57-63. PubMed ID: 3279500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
    Barry AL; Jones RN
    Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
    Neu HC; Labthavikul P
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
    Chin NX; Novelli A; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ; Deforges L; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.